Skip to content

Study comparing ayurveda therapy and standard medicine for gallstone dissolution.

Evaluation of the efficacy of ayurveda therapy comprising rohitakadi churna, kokilaksha kshara, and phaltrikadi kwatha on gallstone dissolution in comparison with ursodeoxycholic acid in patients of cholelithiasis (Pittasaya Ashmari): A randomized controlled trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103513
Enrollment
216
Registered
2026-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis

Interventions

None listed

Sponsors

All india institute of ayurveda new delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering with cholelithiasis in the age group of 18-60 years irrespective of their gender, caste, religion, or socioeconomic status with gallbladder stone size 10 or less than 10.

Exclusion criteria

Exclusion criteria: 1.Acute cholecystitis, complicated cases of cholelithiasis 2.Gallbladder stone size more than 10 mm 3.Malignancy of gallbladder 4.Patient suffering from chronic illness related to CVS, renal, hepatic and GIT. 5.Pregnant women, Lactating mother 6.Patient taking drugs affecting bile acids or serum lipids. Eg. Hypolipidemic drugs, OC pills. 7.Patient having chronic, life threatening and contagious diseases. 8.Patient with any confounders observed during participant recruitement will be excluded.

Design outcomes

Primary

MeasureTime frame
Gallstone dissolution rate and radiological response, assessed by change in gallstone size using ultrasonography (USG) at baseline and after 3 months of treatment.Timepoint: 3 months

Secondary

MeasureTime frame
Symptom score evaluation and To check for any adverse events.Timepoint: Symptom improvement - Change in clinical symptoms (abdominal pain, dyspepsia, nausea, vomiting) from baseline to 3 and 6 months, measured using a validated symptom score/Visual Analogue Scale (VAS). and Safety outcomes - Incidence and severity of adverse events related to Ayurveda therapy or UDCA during the study period.

Countries

India

Contacts

Public ContactProf Dr Yogesh Badwe

ALL INDIA INSTITUTE OF AYURVEDA, NEW DELHI

dryogesh.badwe@gmail.com9011060498

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026